Clinical trial
Lactate Metabolism Study in HIV Infected Persons
NCT00202228 · Queen's University, Other · Completed
Key facts
| NCT number | NCT00202228 |
|---|---|
| Title | Lactate Metabolism Study in HIV Infected Persons |
| Official title | Lactic Acid Metabolism in HIV-Infected Persons. Predicting Abnormalities in Lactate Production and Clearance Related to Treatment and Liver Disease and Measuring the Impact of Vitamin Supplementation. |
| Lead sponsor | Queen's University, Other |
| Collaborators | Ontario HIV Treatment Network |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | HIV Infections, AIDS, Lactic Acidosis, Lipodystrophy |
| Intervention type | Drug |
| Interventions | cofactor supplementation (thiamine, riboflavin, L-carnitine) |
| Enrollment | 30 |
| Start date | Jul 1, 2002 |
| Primary completion | Oct 1, 2008 |
| Completion | Sep 1, 2011 |
| First posted | Sep 20, 2005 |
| Last update posted | Jan 13, 2016 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: